For a patient like the profile Clarkson represents (thyroid comorbidity, years of failed conventional approaches, now responding to pharmacotherapy), the clinical logic for continuation is strong
Unstable concentrations could lead to fluctuating appetite control, inconsistent blood sugar management, and an unpredictable experience of side effects
Our editorial team is independent and only endorses products we believe in
Liraglutide treatment reduced weight and unwanted behavior seemingly by preventing food-related repetitive thoughts and compulsions
Compounded vs branded The compounded vs FDA-approved branded distinction is the single most important medication question on any GLP-1 telehealth platform
Treatments are vehicle (V), cagrilintide (C, 2 nmol/kg), semaglutide (S, 2 nmol/kg), and calorie-restricted to match the weight of the CS rats (weight matched, WM)